Ekso Bionics Holdings Inc
NASDAQ:EKSO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ekso Bionics Holdings Inc
Common Shares Outstanding
Ekso Bionics Holdings Inc
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Common Shares Outstanding
$3.6m
|
CAGR 3-Years
59%
|
CAGR 5-Years
45%
|
CAGR 10-Years
49%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Common Shares Outstanding
$1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Common Shares Outstanding
$580.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Stryker Corp
NYSE:SYK
|
Common Shares Outstanding
$382.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Common Shares Outstanding
$1.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Common Shares Outstanding
$355.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Ekso Bionics Holdings Inc
Glance View
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.
See Also
What is Ekso Bionics Holdings Inc's Common Shares Outstanding?
Common Shares Outstanding
3.6m
USD
Based on the financial report for Dec 31, 2025, Ekso Bionics Holdings Inc's Common Shares Outstanding amounts to 3.6m USD.
What is Ekso Bionics Holdings Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
49%
Over the last year, the Common Shares Outstanding growth was 140%. The average annual Common Shares Outstanding growth rates for Ekso Bionics Holdings Inc have been 59% over the past three years , 45% over the past five years , and 49% over the past ten years .
